Evidence map›Paper›PMID 26987910›Full record

ArticleCirculation research2016

Fortune Favors the Prepared: Safety and Efficacy of Allogeneic Hypoxia Preconditioned Mesenchymal Stromal Cells in Primates.

Gabriela M Kuster, Ronglih Liao

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Gabriela M KusterFrom the Department of Biomedicine and the Division of Cardiology, University Hospital Basel and University of Basel, Basel, Switzerland (G.M.K.); and Divisions of Genetics and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (R.L.).
Ronglih LiaoFrom the Department of Biomedicine and the Division of Cardiology, University Hospital Basel and University of Basel, Basel, Switzerland (G.M.K.); and Divisions of Genetics and Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (R.L.). rliao@rics.bwh.harvard.edu.

Funding

Molecular Mechanisms and Treatment of Primary Amyloid AL CardiomyopathyR01HL088533 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LIAO, RONGLIH · 2007 to 2015
$4.3M
Metabolic underpinnings of AL amyloid cardiomyopathyR01HL128135 · NHLBI · STANFORD UNIVERSITY · PI LIAO, RONGLIH · 2015 to 2018
$2.5M
NHLBI NIH HHS HL088533NHLBI NIH HHS HL128135NHLBI NIH HHS R01 HL088533NHLBI NIH HHS R01 HL128135
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myocardial RevascularizationAnimalsIschemic Preconditioning, MyocardialMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMyocardial InfarctionParacrine Communicationacute myocardial infarctionEditorialhypoxia preconditioningmesenchymal stromal cellsparacrine effectsprimates

Identifiers

PMID26987910
PMCPMC5198302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.